Philippe Sauvage's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 4,000 Class A Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on June 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nuvation Bio Inc Ordinary | Philippe Sauvage | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 16 Jun 2025 | 4,000 | 9,902 | - | 1.8 | 7,160 | Class A Common Stock |
Nuvation Bio Inc Ordinary | Philippe Sauvage | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 16 Jun 2025 | 3,300 | 5,902 | - | 1.8 | 6,056 | Class A Common Stock |
Nuvation Bio Inc Ordinary | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
Nuvation Bio Inc Ordinary | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) |